IperionX has validated titanium powder capacity above 200 tonnes per annum and lifted quarterly production to 8.7 tonnes, while a new U.S. Army task order funds further manufacturing scale-up. The company ended September with US$63.0 million in cash and US$33.7 million of obligated government funding still available for reimbursement.
- HAMR furnace run-rate validated above 200 tpa
- Quarterly titanium powder production rose to 8.7 tonnes
- GenX delivered sixfold throughput with more than 75% lower power use
- U.S. Army Task Order 2 carries US$18.5 million of stated value
- Cash reached US$63.0 million after the US$50 million equity raise
Titanium capacity clears the 200 tpa hurdle
IperionX Limited (ASX:IPX; Nasdaq:IPX) has moved its Virginia operation another step from pilot-style production towards commercial manufacturing, validating HAMR furnace capacity above its targeted 200 tonnes per annum. The company completed 1.6 tonnes of back-to-back deoxygenation runs in 63 hours, equivalent to an annualised rate of about 219 tpa on a continuous basis.
That is a rated-capacity milestone, not a promise of equivalent near-term sales or output. IperionX produced 8.7 tonnes of titanium powder in the September quarter, up from 1.4 tonnes in the June quarter, and held 19 tonnes of finished powder inventory alongside 207 tonnes of titanium scrap feedstock. The company says it will schedule production against customer orders and product-development requirements rather than run continuously at full capacity while inventory covers near-term needs.
The result extends the progress reported in the 24/7 Virginia production ramp, which had lifted nameplate powder capacity to about 200 tpa. Powder drying remains the final major ancillary step yet to reach that run-rate, with full-system validation still targeted for the end of 2026.
GenX points to a lower-input production route
IperionX’s GenX continuous HAMR platform processed more than 500 kilograms of titanium powder across four runs totalling 41 hours. On the company’s like-for-like comparison with batch HAMR, GenX delivered six times the throughput, while reducing power consumption by more than 75%, magnesium use by more than 45% and hydrogen consumption by more than 60% per kilogram of powder.
The current GenX platform was validated at an equivalent run-rate of about 100 tpa, and engineering work is under way to integrate it into a full production line that could add more than 100 tpa of capacity. The result builds on the GenX furnace validation reported in September, although further optimisation is required: one angular powder sample came from an interrupted run and was excluded from the valid sample set, while minor process refinements are planned to bring angular powder within the Grade 23 oxygen limit.
Government funding meets component manufacturing
The quarter also brought a new layer of financial support for the powder-to-part strategy. The U.S. Army awarded Task Order 2 under IperionX’s US$99 million SBIR Phase III IDIQ contract, with a stated base value of US$18.5 million, including US$11.5 million initially funded. Options could take the task order to US$25.4 million, although those options remain subject to exercise and funding.
Task Order 2 is directed at continuous HSPT and dehydride furnace development, plus in-house centreless grinding and thread-rolling equipment for fastener finishing. Together with Task Order 1, the awards have a stated value of about US$19.8 million, leaving US$79.2 million under the broader contract ceiling. The company’s second U.S. Army task order had previously been described as US$11.5 million funded to expand industrial-scale titanium manufacturing.
Downstream activity is becoming more tangible. IperionX produced 1,500 fasteners during the quarter, completed the titanium components under a Carver Pump purchase order for final customer testing, and continued manufacturing track pins for American Rheinmetall Vehicles. A second Elnik HSPT sintering furnace is installed and scheduled for commissioning in the December quarter, while a follow-on U.S. Army GVSC purchase order covers fasteners for the Joint Light Tactical Vehicle and trailer.
Cash supports expansion, but commercial proof remains ahead
IperionX finished the quarter with US$63.0 million in cash, compared with US$35.2 million at June 30, after the July offering generated approximately US$46.1 million in net proceeds. Operating cash outflow was US$12.6 million, while remaining obligated reimbursable U.S. Government funding stood at US$33.7 million. The company therefore reported approximately US$96.7 million of cash and obligated government funding, though reimbursement timing means those sources are not interchangeable in practice.
The adjacent Atlas acquisition closed for US$3 million during the quarter, adding surface stockpiles, pre-stripped mineralisation and established infrastructure to the Titan critical-minerals platform. Titan’s June feasibility study reported an after-tax NPV8 of US$813 million and a 39.4% after-tax IRR, but the integrated Atlas-Titan assessment is still under way and development remains dependent on financing, approvals, construction and operating performance.
The immediate test is conversion rather than capacity alone: Carver Pump testing, track-pin delivery, the second furnace commissioning, powder drying and customer qualification all sit between today’s validated process metrics and recurring commercial orders. The proposed Texas redomiciliation and direct Nasdaq listing add a separate corporate milestone, but remain subject to shareholder, court, regulatory and exchange approvals.
Bottom Line?
IperionX has strengthened the manufacturing and funding base, but the next valuation-sensitive evidence will be qualified components and repeat orders rather than additional nameplate capacity.
Questions in the middle?
- Can Carver Pump testing convert completed components into commercial-scale U.S. Navy contractor orders?
- How quickly will the second HSPT furnace and GenX line integration translate into repeatable, qualified production?
- Will the Atlas-Titan economic study demonstrate a lower-capital development pathway without adding material funding risk?